X-Linked Agammaglobulinemia (XLA)
Introduction And Genetics
X-linked agammaglobulinemia (XLA), also known as Bruton agammaglobulinemia, is a primary immunodeficiency disorder characterized by a profound defect in B-lymphocyte development.
- It primarily affects males and is inherited as an X-linked recessive trait.
- The condition is caused by pathogenic variants in the BTK gene located on locus Xq21.2-22.
Pathophysiology
- The BTK gene encodes the Bruton tyrosine kinase (Btk) protein, which is essential for normal B-cell differentiation and signaling.
- Defective Btk protein results in a developmental arrest of B cells at the pro-B cell to pre-B cell stage in the bone marrow.
- This arrest leads to a near-total absence of circulating CD19+ B cells, which typically comprise less than 1% of peripheral blood lymphocytes.
- T-cell development, T-cell subsets, and cellular immune functions remain intact, and the thymus appears normal.
Clinical Manifestations
Infants with XLA typically remain healthy during the first 6 to 9 months of life due to the protective effect of transplacental maternal immunoglobulin G (IgG). Symptoms typically emerge as maternal antibodies wane.
Physical Examination Findings
- Profound lymphoid hypoplasia is a clinical hallmark.
- Patients classically present with extremely small or absent tonsils and lack palpable lymph nodes.
Infectious Susceptibility
Patients suffer from recurrent, severe infections with specific groups of organisms.
| Pathogen Category | Characteristic Infections In XLA |
|---|---|
| Bacteria | Highly susceptible to extracellular pyogenic organisms, including Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Neisseria meningitidis. These cause recurrent pharyngitis, sinusitis, otitis media, bronchitis, pneumonia, meningitis, and sepsis. |
| Viruses | Most viruses are handled normally, except for enteroviruses and hepatitis viruses. Enteroviruses (e.g., echovirus, coxsackievirus) can cause chronic, fatal meningoencephalitis or a dermatomyositis-like myositis. |
| Parasites And Atypical Organisms | Giardia lamblia infections are common, leading to chronic diarrhea and malabsorption. Ureaplasma urealyticum can cause arthritis in large joints. |
Complications
- Recurrent bronchopulmonary infections frequently lead to chronic obstructive lung disease and bronchiectasis.
- Gastrointestinal involvement can lead to colitis presenting similarly to inflammatory bowel disease.
- Transient severe neutropenia may occur during acute infections, carrying a high risk for Pseudomonas or staphylococcal sepsis.
Laboratory Diagnosis
The diagnosis of XLA relies on evaluating the quantitative immunoglobulins, specific antibody responses, and lymphocyte subpopulations.
| Investigation | Characteristic Findings |
|---|---|
| Immunoglobulin Profile | Severe hypogammaglobulinemia is present. Total serum immunoglobulins are usually <100 mg/dL. IgG, IgA, IgM, and IgE levels are all profoundly decreased. |
| Specific Antibodies | Isohemagglutinins (natural antibodies to blood group antigens) are abnormally low or absent. Patients fail to mount antibody responses to routine vaccine antigens. |
| Flow Cytometry | Circulating CD19+ and CD20+ B cells are markedly decreased or absent. CD3+, CD4+, and CD8+ T cells, along with natural killer (NK) cells, are normal or increased. |
| Molecular Diagnostics | Genetic testing confirms the diagnosis by identifying pathogenic variants in the BTK gene. |
Management
Therapy focuses on passive immune reconstitution and strict infection control.
Immunoglobulin Replacement Therapy (IgRT)
- Lifelong immunoglobulin replacement, administered either intravenously (IVIG) or subcutaneously (SCIG), is the standard of care.
- Maintaining IgG trough levels above 800 to 1,000 mg/dL is crucial to prevent serious bacterial illness, pneumonia, and enteroviral meningoencephalitis.
Antimicrobial Therapy And Prophylaxis
- Aggressive treatment of documented infections with appropriate antibiotics is essential.
- Continuous prophylactic antibiotics (such as azithromycin) may be utilized in conjunction with IgRT for patients who suffer from recurrent respiratory tract infections or existing bronchiectasis.
Immunization Precautions
- Administration of live viral vaccines is strictly contraindicated.
- The live attenuated oral polio vaccine (OPV) carries a significant risk of inducing vaccine-associated paralytic poliomyelitis in these patients.